Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Cancer Tumors May Protect Against Alzheimer's by Cleaning Protein Clumps
Study finds cancer tumors secrete Cystatin-C protein to clean amyloid clumps in Alzheimer's brains, activating microglia to reverse damage.
Enzyme-Blocking Treatment Reverses Chronic Pain in Preclinical Study
Virginia Tech scientists found blocking an enzyme system reverses nociplastic chronic pain in mice, offering a potential new non-opioid treatment.
IGC Pharma Adds New York Site for CALMA Phase II Alzheimer’s Disease Trial
IGC Pharma expands CALMA Phase II trial for IGC-AD1 in Alzheimer’s agitation by adding Integrative Clinical Trials in New York to its network.
BMS Signs $850m Deal with Janux for Novel Solid Tumour Therapy
BMS signs $850m deal with Janux for solid tumour therapy to bolster oncology pipeline amid Opdivo and Eliquis patent expiries.
Corcept Stock Rises as Relacorilant Meets OS Goal in Phase III Ovarian Cancer
Corcept stock rose 14% after relacorilant met overall survival goal in the Phase III ROSELLA trial for platinum-resistant ovarian cancer.
Olatec Presents Preclinical Evidence of Dapansutrile Activity in Parkinson's
Olatec Therapeutics presented preclinical data showing dapansutrile produces disease-modifying effects in Parkinson's disease models at MJFF forum.
Shionogi Expands ViiV Healthcare Stake to 21.7% as Pfizer Exits
Shionogi invests $2.13bn in ViiV Healthcare, increasing stake to 21.7%. Pfizer sells its 11.7% interest. GSK retains majority 78.3% stake.
Sandoz Optimistic on Golden Decade for US Biosimilars and Affordable Medicines
Sandoz eyes $322B opportunity in the biosimilar void, predicting a golden decade of affordable medicines despite US market challenges.
Worldwide Clinical Trials to Acquire Oncology CRO Catalyst Clinical Research
Worldwide Clinical Trials enters agreement to acquire oncology CRO Catalyst Clinical Research. Deal to conclude Q1 2026, enhancing global reach.
BioNxt ODF Cladribine Shows 40% Higher Delivery for Multiple Sclerosis
BioNxt reports sublingual ODF cladribine achieved 40% higher systemic delivery than oral tablets for Multiple Sclerosis treatment in preclinical study.
FDA Grants Breakthrough Therapy to Novartis' Ianalumab for Sjögren's Disease
Novartis receives FDA Breakthrough Therapy tag for ianalumab treating Sjögren's disease after positive Phase III NEPTUNUS results. Filings in 2026.
Indian Pharma Exports Surge: Brazil & Nigeria Emerge as Key Markets in FY26
Indian pharmaceutical exports rose 6.5% to $20.48B. Brazil and Nigeria join the US as top destinations for Indian generics in April-November FY26.
7
8
9
10
11
12
13
14
15
